May 1, 2026 Celcuity’s Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
May 1, 2026 Exodus Movement Acquires Outstanding Shares of Monavate Holdings Limited and Baanx.com Ltd.